Takeda’s generic business is acquired by Sun Pharma subsidiary
Sun Pharmaceuticals has announced that its wholly-owned subsidiary, Caraco Pharmaceutical Laboratories, has entered into a definitive agreement with Takeda Pharmaceuticals to buy its URL Pharma generic business.
Japanese drug maker, Takeda, acquired URL Pharma, a formerly privately-held Philadelphia-based pharmaceutical company, in June 2012.
Upon completion of the purchase, the non-Colcrys (colchicine, USP) generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals.
Sun Pharma arm to buy generics business of US-based URL Pharma (Business Today)
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.